190 related articles for article (PubMed ID: 15714988)
41. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
Mäkinen K; Loimas S; Wahlfors J; Alhava E; Jänne J
J Gene Med; 2000; 2(5):361-7. PubMed ID: 11045430
[TBL] [Abstract][Full Text] [Related]
42. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
Lambright ES; Amin K; Wiewrodt R; Force SD; Lanuti M; Propert KJ; Litzky L; Kaiser LR; Albelda SM
Gene Ther; 2001 Jun; 8(12):946-53. PubMed ID: 11426335
[TBL] [Abstract][Full Text] [Related]
43. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
[TBL] [Abstract][Full Text] [Related]
44. Cytopathic effect of in situ gene therapy in prostate cancer.
Ayala G; Wheeler TM; Shalev M; Thompson TC; Miles B; Aguilar-Cordova E; Chakraborty S; Kadmon D
Hum Pathol; 2000 Jul; 31(7):866-70. PubMed ID: 10923926
[TBL] [Abstract][Full Text] [Related]
45. Is gene therapy the answer for prostate cancer?
Patel P; Ashdown D; James N
Prostate Cancer Prostatic Dis; 2004 Sep; 7 Suppl 1():S14-9. PubMed ID: 15365577
[TBL] [Abstract][Full Text] [Related]
46. [French clinical trials of gene therapy with "suicide gene"].
Jeanteur P
Bull Cancer; 1999 Feb; 86(2):137-8. PubMed ID: 10094522
[No Abstract] [Full Text] [Related]
47. [All-trans retinoic acid enhances bystander effect of suicide-gene therapy against androgen-unresponsive prostate cancer].
Chen WG; Yan CY; Hou JQ; Wen DG; Pu JX; Wang HB
Zhonghua Nan Ke Xue; 2008 Feb; 14(2):122-5. PubMed ID: 18390175
[TBL] [Abstract][Full Text] [Related]
48. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer.
Freytag SO; Khil M; Stricker H; Peabody J; Menon M; DePeralta-Venturina M; Nafziger D; Pegg J; Paielli D; Brown S; Barton K; Lu M; Aguilar-Cordova E; Kim JH
Cancer Res; 2002 Sep; 62(17):4968-76. PubMed ID: 12208748
[TBL] [Abstract][Full Text] [Related]
49. Gene therapy for prostate cancer: where are we now?
Steiner MS; Gingrich JR
J Urol; 2000 Oct; 164(4):1121-36. PubMed ID: 10992352
[TBL] [Abstract][Full Text] [Related]
50. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
Sterman DH; Recio A; Vachani A; Sun J; Cheung L; DeLong P; Amin KM; Litzky LA; Wilson JM; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Oct; 11(20):7444-53. PubMed ID: 16243818
[TBL] [Abstract][Full Text] [Related]
51. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
Bilbao R; Gérolami R; Bralet MP; Qian C; Tran PL; Tennant B; Prieto J; Bréchot C
Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
[TBL] [Abstract][Full Text] [Related]
52. [Gene therapy for lung cancer treatment].
Takayama K; Nakanishi Y; Hara N
Nihon Rinsho; 2000 May; 58(5):1048-52. PubMed ID: 10824547
[TBL] [Abstract][Full Text] [Related]
53. Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene.
Shalev M; Miles BJ; Thompson TC; Ayala G; Butler EB; Aguilar-Cordova E; Kadmon D
World J Urol; 2000 Apr; 18(2):125-9. PubMed ID: 10854147
[TBL] [Abstract][Full Text] [Related]
54. [Gene therapy for the treatment of prostate cancer using osteocalcin promoter].
Gotoh A; Terao S; Shirakawa T; Fujisawa M; Kamidono S
Nihon Rinsho; 2011 Jun; 69 Suppl 5():550-3. PubMed ID: 22208042
[No Abstract] [Full Text] [Related]
55. [Gene therapy for colon cancer].
Suehiro Y; Hamanaka Y; Hinoda Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():533-6. PubMed ID: 16416848
[No Abstract] [Full Text] [Related]
56. Gene therapy in human cancer: report of human clinical trials.
Wasil T; Buchbinder A
Cancer Invest; 2000; 18(8):740-6. PubMed ID: 11107444
[No Abstract] [Full Text] [Related]
57. [Suicide gene and immuno gene therapy for prostate cancer].
Nasu Y; Sasaki K; Kumon H; Kaku H; Watanabe M
Nihon Rinsho; 2011 Jun; 69 Suppl 5():554-8. PubMed ID: 22208043
[No Abstract] [Full Text] [Related]
58. [Gene therapy for breast cancer].
Miki Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():522-5. PubMed ID: 16416846
[No Abstract] [Full Text] [Related]
59. Gene therapy for mesothelioma and lung cancer.
Vachani A; Moon E; Wakeam E; Albelda SM
Am J Respir Cell Mol Biol; 2010 Apr; 42(4):385-93. PubMed ID: 20160042
[TBL] [Abstract][Full Text] [Related]
60. [Gene therapies for bladder cancer].
Satoh M; Wang H; Arai Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():548-51. PubMed ID: 16416851
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
